Rapid Communication

Cloning and mutational analysis of human malonyl-coenzyme A decarboxylase

Correspondence to: Jonathan C. Cohen

Malonyl coenzyme A (CoA) decarboxylase (E.C.4. 1.1.9) catalyzes the conversion of malonyl CoA to acetyl CoA. The metabolic role of malonyl CoA decarboxylase has not been fully defined, but deficiency of the enzyme has been associated with mild mental retardation, seizures, hypotonia, cardiomyopathy, vomiting, hypoglycemia, metabolic acidosis, and malonic aciduria. Here we report the isolation and sequencing of the human gene encoding malonyl CoA decarboxylase, and the identification of a mutation causing malonyl CoA decarboxylase deficiency. Human malonyl CoA decarboxylase cDNA sequences were identified by homology to the goose gene, and the intron/exon boundaries were determined by direct sequencing of a PAC clone containing the entire human gene. The 1479 basepair human cDNA is 70 percent identical to the goose sequence, and the intron/exon boundaries are completely conserved between the two species. The genetic mutation underlying malonyl CoA decarboxylase deficiency was determined in a patient with clinical features of this defect, malonic aciduria, and markedly reduced malonyl CoA decarboxylase activity.—Gao, J., L. Waber, M. J. Bennett, K. M. Gibson, and J. C. Cohen. Cloning and mutational analysis of human malonyl-coenzyme A decarboxylase. J. Lipid Res. 1999. 40: 178–182.

Supplementary key words: microbodies, mitochondria, frameshift mutation, metabolism, inborn errors

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. R. Ussher and G. D. Lopaschuk The malonyl CoA axis as a potential target for treating ischaemic heart disease Cardiovasc Res, July 15, 2008; 79(2): 259 - 268. [Abstract] [Full Text] [PDF]

				J. R.B. Dyck, T. A. Hopkins, S. Bonnet, E. D. Michelakis, M. E. Young, M. Watanabe, Y. Kawase, K.-i. Jishage, and G. D. Lopaschuk Absence of Malonyl Coenzyme A Decarboxylase in Mice Increases Cardiac Glucose Oxidation and Protects the Heart From Ischemic Injury Circulation, October 17, 2006; 114(16): 1721 - 1728. [Abstract] [Full Text] [PDF]

				A. Boucher, D. Lu, S. C. Burgess, S. Telemaque-Potts, M. V. Jensen, H. Mulder, M.-Y. Wang, R. H. Unger, A. D. Sherry, and C. B. Newgard Biochemical Mechanism of Lipid-induced Impairment of Glucose-stimulated Insulin Secretion and Reversal with a Malate Analogue J. Biol. Chem., June 25, 2004; 279(26): 27263 - 27271. [Abstract] [Full Text] [PDF]

				R. Santer, R. Fingerhut, U. Lassker, P. J. Wightman, D. R. Fitzpatrick, B. Olgemoller, and A. A. Roscher Tandem Mass Spectrometric Determination of Malonylcarnitine: Diagnosis and Neonatal Screening of Malonyl-CoA Decarboxylase Deficiency Clin. Chem., April 1, 2003; 49(4): 660 - 662. [Full Text] [PDF]

				F. M. Campbell, R. Kozak, A. Wagner, J. Y. Altarejos, J. R. B. Dyck, D. D. Belke, D. L. Severson, D. P. Kelly, and G. D. Lopaschuk A Role for Peroxisome Proliferator-activated Receptor alpha (PPARalpha ) in the Control of Cardiac Malonyl-CoA Levels. REDUCED FATTY ACID OXIDATION RATES AND INCREASED GLUCOSE OXIDATION RATES IN THE HEARTS OF MICE LACKING PPARalpha ARE ASSOCIATED WITH HIGHER CONCENTRATIONS OF MALONYL-CoA AND REDUCED EXPRESSION OF MALONYL-CoA DECARBOXYLASE J. Biol. Chem., February 1, 2002; 277(6): 4098 - 4103. [Abstract] [Full Text] [PDF]

				H. Mulder, D. Lu, J. Finley IV, J. An, J. Cohen, P. A. Antinozzi, J. D. McGarry, and C. B. Newgard Overexpression of a Modified Human Malonyl-CoA Decarboxylase Blocks the Glucose-induced Increase in Malonyl-CoA Level but Has No Impact on Insulin Secretion in INS-1-derived (832/13) beta -Cells J. Biol. Chem., February 23, 2001; 276(9): 6479 - 6484. [Abstract] [Full Text] [PDF]